Toronto Dominion Bank
BLACR

Toronto Dominion Bank’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Toronto Dominion Bank’s Portfolio BLACR Stock Details BLACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-446,448
Closed -$48.7K – 1761
2024
Q4 		$48.7K Buy
+446,448
New +$56K ﹤0.01% 1389

Toronto Dominion Bank's BLACR Position: Q1 2025 in Review

Toronto Dominion Bank sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q1 2025, closing a stake of 446,448 shares — an estimated $48.7K sold.

Toronto Dominion Bank first reported a position in BLACR in Q4 2024 and held it in 1 quarter. The position peaked at $48.7K in Q4 2024. 0 funds tracked by Wall St. Rank hold BLACR as of Q1 2025.

  • Toronto Dominion Bank reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q1 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 446,448 Bellevue Life Sciences Acquisition Corp. Rights shares in Q1 2025, an estimated $48.7K.
  • Toronto Dominion Bank first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q4 2024 and held it in 1 quarter.
  • Toronto Dominion Bank's Bellevue Life Sciences Acquisition Corp. Rights position peaked at $48.7K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q1 2025.

Based on Toronto Dominion Bank's 13F filing for Q1 2025, filed 15 May 2025.